Local News

Biolex Reports Progress in Hepatitis C Treatment

Posted Updated

PITTSBORO, N.C. — Biolex Therapeutics

reported positive results in a Phase I trial of a proposed drug to treat Hepatitis C.

Biolex is developing the drug Locteron along with OctoPlus, a firm based in the Netherlands.

The drug is centered around a compound, BLX-883, developed by Biolex and a controlled-release drug delivery system designed by OctoPlus.

The two companies plan to launch Phase II clinical testing in the second half of this year.

Copyright 2024 by Capitol Broadcasting Company. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.